$33.99 0.00 (0%)
10/13/2008 4:00 PM

ICOS CP (NASDAQ:ICOS.DL)

CAPS Rating: No stars

A biotechnology company, which through Lilly ICOS LLC, markets Cialis (tadalafil) for the treatment of erectile dysfunction. Works to develop potential treatments for other serious unmet medical conditions such as cancer and inflammatory diseases.

Featured Broker Partners


Advertisement